OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pharmaceutical Sciences is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Scale-up and clinical bioavailability assessment of a 45% drug loaded amorphous nanoparticle formulation of a BCS IV compound for oral delivery	140
Application of atomic force microscopy in the development of amorphous solid dispersion	134
Structural studies on the interaction of CTAB with alginate: Possibility of surfactant therapy with chemo sensitization effect	107
Sustained release of RNA nanoparticles from reservoir implant for ocular delivery	86
Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection	84
A Modern Approach to Stability Studies via Bayesian Linear Mixed Models Incorporating Auxiliary Effects	78
Colloidal packing fraction in sedimented aluminum adjuvants dictate their resuspension rheology	64
Mannitol as an Excipient for Lyophilized Injectable Formulations	64
3D printing of dose-flexible crystalline solid dispersion tablets suitable for preclinical and first-in-human studies	63
On Harvesting and Handling of Porcine Jejunal Mucus: A Few Tricks of the Trade	60
Preparation and Characterization of Platelet Lysate (Pl)-Loaded Electrospun Nanofibers for Epidermal Wound Healing	58
Salt Solubility and Disproportionation – Uses and Limitations of Equations for pHmax and the In-silico Prediction of pHmax	55
Co-Crystals of Etravirine by Mechanochemical Activation	55
Physiologically Based Pharmacokinetic Modeling of 3 HIV Drugs in Combination and the Role of Lymphatic System after Subcutaneous Dosing. Part 2: Model for the Drug-combination Nanoparticles	53
Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy	50
PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model	49
Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design	48
Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase Separation	46
Assessment of Drug–drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model	46
Development of Fully Redispersible Dried Nanocrystals by Using Sucrose Laurate as Stabilizer for Increasing Surface Area and Dissolution Rate of Poorly Water-Soluble Drugs	45
The Enhanced Skin Permeation of Flavonoids Via the Application of a Coamorphous in a Microemulsion Formulation	45
In Vitro Drug Release Testing Method For Nepafenac Ophthalmic Suspension	43
The Application of Virtual Therapeutic Drug Monitoring to Assess the Pharmacokinetics of Imatinib in a Chinese Cancer Population Group	43
Uptake Pathway of Styrene Maleic Acid Copolymer-Coated Lipid Emulsions Under Acidic Tumor Microenvironment	43
Development, Characterization and In Vitro Antimicrobial Evaluation of Novel Flavonoids Entrapped Micellar Topical Formulations of Neomycin Sulfate	42

Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations	42
Natural drugs: Trends, properties, and decline in FDA approvals	41
Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens	41
Physiologically-based pharmacokinetic modeling of rosuvastatin in Chinese: Predicting the impact of SLCO1B1 and ABCG2 genetic variants and hepatic impairment on drug exposure	40
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP)	39
Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis	39
Exploring a new approach in biopharmaceutics to improve the estimation of stomach solubilization from the mathematical model with a single stomach compartment setting: The impact of stomach solubiliza	39
Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application	37
Advanced Chemical and Imaging Methods for Studying Structure Morphology and Excipients Solid State Transformations in Pharmaceutical Multiparticulate Formulations	37
Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?	37
Metal-induced oxidation of polysorbate 80 in the presence of hydrogen peroxide: Mechanistic studies	36
Impact of dissolution medium pH and ionization state of the drug on the release performance of amorphous solid dispersions	36
Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies	36
Accelerated and Biopredictive In Vitro Release Testing Strategy for Single Agent and Combination Long-Acting Injectables	36